| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1039149383 |
| P356 | DOI | 10.1007/S10555-010-9224-5 |
| P932 | PMC publication ID | 4012531 |
| P698 | PubMed publication ID | 20393783 |
| P50 | author | Amato J. Giaccia | Q110591782 |
| P2093 | author name string | Elizabeth C Finger | |
| P2860 | cites work | Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells | Q74040126 |
| Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer | Q74448985 | ||
| Expression of connective tissue growth factor in human renal fibrosis | Q74462450 | ||
| Connective tissue growth factor: a novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? | Q77321324 | ||
| Expression of fibrogenic cytokines in desmoplastic malignant melanoma | Q77393461 | ||
| Connective tissue growth factor gene expression alters tumor progression in esophageal cancer | Q77811241 | ||
| Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer | Q80207404 | ||
| Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors | Q80344477 | ||
| Matrix metalloproteinase-9 (MMP-9) elevated in serum but not in bronchial lavage fluid in patients with lung cancer | Q83842589 | ||
| Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis | Q83894901 | ||
| C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation | Q24291783 | ||
| Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity | Q24297858 | ||
| Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression | Q24300340 | ||
| A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression | Q24314451 | ||
| Collagenolytic activity in amphibian tissues: a tissue culture assay | Q24648397 | ||
| Inflammation and cancer | Q24649640 | ||
| Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer | Q24650026 | ||
| Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis | Q24669710 | ||
| Lysyl oxidase is essential for normal development and function of the respiratory system and for the integrity of elastic and collagen fibers in various tissues | Q24675315 | ||
| Hypoxia Attenuates the Expression of E-Cadherin via Up-Regulation of SNAIL in Ovarian Carcinoma Cells | Q24685207 | ||
| Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation | Q27860876 | ||
| The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages | Q28143066 | ||
| Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation | Q28188357 | ||
| Demonstration of in vitro interaction between tumor suppressor lysyl oxidase and histones H1 and H2: definition of the regions involved | Q28189972 | ||
| Lysyl oxidases: a novel multifunctional amine oxidase family | Q28201099 | ||
| Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene | Q28202069 | ||
| Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell | Q28208372 | ||
| A molecular role for lysyl oxidase in breast cancer invasion | Q28216721 | ||
| RETRACTED: Lysyl oxidase is essential for hypoxia-induced metastasis | Q28236828 | ||
| The cross-linking of collagen and elastin: enzymatic conversion of lysine in peptide linkage to alpha-aminoadipic-delta-semialdehyde (allysine) by an extract from bone | Q28251134 | ||
| Lysyl oxidase mediates hypoxic control of metastasis | Q28271667 | ||
| Metalloproteinase activity secreted by fibrogenic cells in the processing of prolysyl oxidase. Potential role of procollagen C-proteinase | Q28279434 | ||
| HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia | Q28300406 | ||
| Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice | Q28510969 | ||
| Fully processed lysyl oxidase catalyst translocates from the extracellular space into nuclei of aortic smooth-muscle cells | Q28568824 | ||
| Metalloproteinase Activity Secreted by Fibrogenic Cells in the Processing of Prolysyl Oxidase | Q29544584 | ||
| Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis | Q29547178 | ||
| Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy | Q29547379 | ||
| Cancer statistics, 2009 | Q29547625 | ||
| Integrins in cancer: biological implications and therapeutic opportunities | Q29614536 | ||
| Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis | Q29617644 | ||
| Stromal fibroblasts in cancer initiation and progression | Q29618873 | ||
| Basement membranes: structure, assembly and role in tumour angiogenesis | Q29622882 | ||
| An overview of epithelio-mesenchymal transformation | Q30014826 | ||
| Matrix metalloproteinases: a tail of a frog that became a prince | Q33337157 | ||
| Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications | Q33692926 | ||
| Infections as a major preventable cause of human cancer | Q33916455 | ||
| The modular architecture of a new family of growth regulators related to connective tissue growth factor | Q34306420 | ||
| Hypoxia, melanocytes and melanoma - survival and tumor development in the permissive microenvironment of the skin | Q34570988 | ||
| Snail regulates cell-matrix adhesion by regulation of the expression of integrins and basement membrane proteins. | Q35676694 | ||
| Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative study | Q36087887 | ||
| Recombinant human erythropoietin in oncology: current status and further developments | Q36164274 | ||
| The fallacy of epithelial mesenchymal transition in neoplasia | Q36197878 | ||
| Ultrastructural immunolocalization of lysyl oxidase in vascular connective tissue | Q36215340 | ||
| Matrix metalloproteinases: role in arthritis | Q36251020 | ||
| Correlation between the tumoral expression of beta3-integrin and outcome in cervical cancer patients who had undergone radiotherapy | Q36615716 | ||
| Hyperbaric oxygen therapy for malignancy: a review. | Q36653195 | ||
| Hypoxia, gene expression, and metastasis | Q36801457 | ||
| Prevention of hypoxia by myoglobin expression in human tumor cells promotes differentiation and inhibits metastasis | Q37143367 | ||
| Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts | Q37285034 | ||
| Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03. | Q37347497 | ||
| The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth | Q37353804 | ||
| Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling | Q37365541 | ||
| EMT, the cytoskeleton, and cancer cell invasion | Q37377630 | ||
| Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer | Q37412311 | ||
| Role of hypoxia in the hallmarks of human cancer | Q37500308 | ||
| Hypoxia, angiogenesis and cancer therapy: to breathe or not to breathe? | Q37601177 | ||
| TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion | Q37678189 | ||
| Hypoxic induction of Ctgf is directly mediated by Hif-1. | Q38337618 | ||
| Lo, and the niche is knit: lysyl oxidase activity and maintenance of lung, aorta, and skin integrity | Q38596551 | ||
| Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha | Q40063538 | ||
| Alterations in DNA repair gene expression under hypoxia: elucidating the mechanisms of hypoxia-induced genetic instability | Q40335526 | ||
| beta-catenin signaling and regulation of cyclin D1 promoter in NRK-49F cells transformed by down-regulation of the tumor suppressor lysyl oxidase | Q40411627 | ||
| The relationship between bone metastasis from human breast cancer and integrin alpha(v)beta3 expression. | Q40437776 | ||
| Phase I evaluation of a fully human anti-alphav integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors. | Q40453891 | ||
| Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. | Q40731011 | ||
| Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness | Q40760011 | ||
| Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line | Q40772926 | ||
| Extracellular matrix from embryonic myocardium elicits an early morphogenetic event in cardiac endothelial differentiation | Q41454169 | ||
| Cancer and infection: estimates of the attributable fraction in 1990. | Q41498906 | ||
| Post-translational glycosylation and proteolytic processing of a lysyl oxidase precursor. | Q41628295 | ||
| Opposing effects of hypoxia on expression of the angiogenic inhibitor thrombospondin 1 and the angiogenic inducer vascular endothelial growth factor. | Q41750906 | ||
| Desmoplastic reaction influences pancreatic cancer growth behavior | Q42468547 | ||
| A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer | Q42522113 | ||
| Autocrine transforming growth factor-beta signaling mediates Smad-independent motility in human cancer cells. | Q42527689 | ||
| The proteolytic processing site of the precursor of lysyl oxidase. | Q42824263 | ||
| Lysyl oxidase expression is an independent marker of prognosis and a predictor of lymph node metastasis in oral and oropharyngeal squamous cell carcinoma (OSCC). | Q43264716 | ||
| Expression of integrin alphaVbeta3 in pancreatic carcinoma: relation to MMP-2 activation and lymph node metastasis. | Q44079888 | ||
| Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha | Q44108492 | ||
| Lysyl oxidase is required for vascular and diaphragmatic development in mice | Q44243394 | ||
| Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas | Q44418604 | ||
| Comparative immunocytochemical localization of lysyl oxidase (LOX) and the lysyl oxidase-like (LOXL) proteins: changes in the expression of LOXL during development and growth of mouse tissues | Q45194238 | ||
| Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. | Q45969475 | ||
| Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. | Q46033311 | ||
| E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs. | Q51531889 | ||
| Regulation of E-cadherin expression by VHL and hypoxia-inducible factor. | Q53347755 | ||
| Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. | Q55044320 | ||
| Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery. | Q55474171 | ||
| Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. | Q55476886 | ||
| Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells | Q60609535 | ||
| Tumor oxygenation and reoxygenation during radiation therapy: their importance in predicting tumor response | Q69491072 | ||
| Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature | Q69651963 | ||
| Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders | Q71049546 | ||
| Integrin alpha V beta 3 expression by bone-residing breast cancer metastases | Q71312522 | ||
| Histone H1 is a substrate for lysyl oxidase and contains endogenous sodium borotritide-reducible residues | Q72561527 | ||
| Expression of connective tissue growth factor in cartilaginous tumors | Q73025432 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| P304 | page(s) | 285-293 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | Cancer and Metastasis Reviews | Q2647982 |
| P1476 | title | Hypoxia, inflammation, and the tumor microenvironment in metastatic disease | |
| P478 | volume | 29 |
| Q35797158 | 18F-EF5 PET Is Predictive of Response to Fractionated Radiotherapy in Preclinical Tumor Models |
| Q34979821 | 18F-FAZA PET imaging response tracks the reoxygenation of tumors in mice upon treatment with the mitochondrial complex I inhibitor BAY 87-2243 |
| Q60301430 | A 3D microvascular network model to study the impact of hypoxia on the extravasation potential of breast cell lines |
| Q24322269 | A Cullin3-KLHL20 Ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression |
| Q92541443 | A Tailored Multifunctional Anticancer Nanodelivery System for Ruthenium-Based Photosensitizers: Tumor Microenvironment Adaption and Remodeling |
| Q30010277 | A concerted HIF-1α/MT1-MMP signalling axis regulates the expression of the 3BP2 adaptor protein in hypoxic mesenchymal stromal cells |
| Q33889245 | A new method for isolation of interstitial fluid from human solid tumors applied to proteomic analysis of ovarian carcinoma tissue |
| Q36040206 | ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis. |
| Q38114319 | Acid-sensing ion channels under hypoxia |
| Q35810840 | Active roles of tumor stroma in breast cancer metastasis |
| Q35085751 | Akt2 regulates all Akt isoforms and promotes resistance to hypoxia through induction of miR-21 upon oxygen deprivation |
| Q58702062 | All-Trans Retinoic Acid Enhances Matrix Metalloproteinase 2 Expression and Secretion in Human Myeloid Leukemia THP-1 Cells |
| Q39141556 | An iTRAQ based quantitative proteomic strategy to explore novel secreted proteins in metastatic hepatocellular carcinoma cell lines |
| Q64941725 | Anti-inflammation and Anti-Cancer Activity of Ethanol Extract of Antarctic Freshwater Microalga, Micractinium sp. |
| Q30399006 | Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia |
| Q52646033 | Antitumor effect of a Pt-loaded nanocomposite based on graphene quantum dots combats hypoxia-induced chemoresistance of oral squamous cell carcinoma. |
| Q47137400 | BMPR2 and HIF1-α overexpression in resected osteosarcoma correlates with distant metastasis and patient survival |
| Q37264934 | BRG1 and BRM chromatin-remodeling complexes regulate the hypoxia response by acting as coactivators for a subset of hypoxia-inducible transcription factor target genes |
| Q40202794 | BRMS1 gene expression may be associated with clinico-pathological features of breast cancer |
| Q35600151 | Bioengineering embryonic stem cell microenvironments for the study of breast cancer |
| Q89765517 | Biophysical Regulation of Cancer Stem/Initiating Cells: Implications for Disease Mechanisms and Translation |
| Q38259683 | Bone marrow-derived stem cell therapy for metastatic brain cancers |
| Q37662627 | CTGF is a therapeutic target for metastatic melanoma. |
| Q91825034 | Cancer-educated mesenchymal stem cells promote the survival of cancer cells at primary and distant metastatic sites via the expansion of bone marrow-derived-PMN-MDSCs |
| Q37106779 | Cbl-b promotes cell detachment via ubiquitination of focal adhesion kinase |
| Q26851836 | Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis |
| Q86911827 | Characterization of clear cell renal cell carcinoma by gene expression profiling |
| Q39387590 | Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia |
| Q90571077 | Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking In Vitro Models in Anti-Cancer Drug Development |
| Q35575974 | Chronic inflammation and immunologic-based constraints in malignant disease |
| Q92840556 | Cisplatin inhibits the growth, migration and invasion of cervical cancer cells by down-regulating IL-17E/IL-17RB |
| Q37437301 | Crosstalk between the HIF-1 and Toll-like receptor/nuclear factor-κB pathways in the oral squamous cell carcinoma microenvironment |
| Q92736052 | Decoding the Biology of Exosomes in Metastasis |
| Q36261594 | Decreased expression of mucin 18 is associated with unfavorable postoperative prognosis in patients with clear cell renal cell carcinoma |
| Q39636162 | Development path and current status of the NANIVID: a new device for cancer cell studies |
| Q34218825 | Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers |
| Q84972901 | Differential response to CoCl2-stimulated hypoxia on HIF-1α, VEGF, and MMP-2 expression in ligament cells |
| Q51079367 | Dynamic contrast-enhanced MR imaging in predicting progression of enhancing lesions persisting after standard treatment in glioblastoma patients: a prospective study. |
| Q36020972 | Elevated MARCKS phosphorylation contributes to unresponsiveness of breast cancer to paclitaxel treatment |
| Q47098374 | Elevation of adenylate energy charge by angiopoietin-like 4 enhances epithelial-mesenchymal transition by inducing 14-3-3γ expression |
| Q42424347 | Escaping from, moving towards, following a path, squeezing through: lots of opportunities for moving cells |
| Q34569444 | Evaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures |
| Q28397739 | Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development |
| Q37001207 | Expression and clinical significance of glucose transporter-1 in pancreatic cancer |
| Q37610995 | Expression of metastasis suppressor BRMS1 in breast cancer cells results in a marked delay in cellular adhesion to matrix. |
| Q51563028 | Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis. |
| Q38783439 | Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis |
| Q39389732 | Extracellular Vesicles in Renal Pathophysiology. |
| Q37580365 | Extracellular translationally controlled tumor protein promotes colorectal cancer invasion and metastasis through Cdc42/JNK/ MMP9 signaling. |
| Q35938289 | Flavokawain B induced cytotoxicity in two breast cancer cell lines, MCF-7 and MDA-MB231 and inhibited the metastatic potential of MDA-MB231 via the regulation of several tyrosine kinases In vitro |
| Q38867010 | Fucoidan Suppresses Hypoxia-Induced Lymphangiogenesis and Lymphatic Metastasis in Mouse Hepatocarcinoma |
| Q91755999 | Fucoidan inhibits epithelial-to-mesenchymal transition via regulation of the HIF-1α pathway in mammary cancer cells under hypoxia |
| Q34735661 | Glial progenitors as targets for transformation in glioma |
| Q92631456 | Global extracellular vesicle proteomic signature defines U87-MG glioma cell hypoxic status with potential implications for non-invasive diagnostics |
| Q40220883 | H2O2-responsive liposomal nanoprobe for photoacoustic inflammation imaging and tumor theranostics via in vivo chromogenic assay |
| Q33611004 | HIFs enhance the transcriptional activation and splicing of adrenomedullin |
| Q54354561 | Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer. |
| Q49205660 | Herbal compound Teng-Long-Bu-Zhong-Tang inhibits metastasis in human RKO colon carcinoma |
| Q36175681 | High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases |
| Q30365660 | High-precision, non-invasive anti-microvascular approach via concurrent ultrasound and laser irradiation. |
| Q37092893 | Hyperbaric oxygen preconditioning attenuates hyperglycemia-enhanced hemorrhagic transformation by inhibiting matrix metalloproteinases in focal cerebral ischemia in rats. |
| Q34820282 | Hypoxia and the extracellular matrix: drivers of tumour metastasis |
| Q38935440 | Hypoxia induced E-cadherin involving regulators of Hippo pathway due to HIF-1α stabilization/nuclear translocation in bone metastasis from breast carcinoma. |
| Q35762937 | Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9 |
| Q35987892 | Hypoxia induces IGFBP3 in esophageal squamous cancer cells through HIF-1α-mediated mRNA transcription and continuous protein synthesis |
| Q47218239 | Hypoxia induces epithelial-mesenchymal transition in colorectal cancer cells through ubiquitin-specific protease 47-mediated stabilization of Snail: A potential role of Sox9. |
| Q47930181 | Hypoxia mediates mitochondrial biogenesis in hepatocellular carcinoma to promote tumor growth through HMGB1 and TLR9 interaction. |
| Q34177914 | Hypoxia regulates alternative splicing of HIF and non-HIF target genes. |
| Q27319546 | Hypoxia regulates global membrane protein endocytosis through caveolin-1 in cancer cells. |
| Q52595311 | Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins. |
| Q34117013 | Hypoxia-induced invadopodia formation involves activation of NHE-1 by the p90 ribosomal S6 kinase (p90RSK). |
| Q92372553 | Hypoxia-induced tumor exosomes promote M2-like macrophage polarization of infiltrating myeloid cells and microRNA-mediated metabolic shift |
| Q38051286 | Hypoxia-inducible factors as key regulators of tumor inflammation |
| Q37843943 | Hypoxia-mediated biological control |
| Q57183552 | Hypoxia-sensitive bis(2-(2'-benzothienyl)pyridinato-N,C(3'))iridium[poly(n-butyl cyanoacrylate]/chitosan nanoparticles and their phosphorescence tumor imaging in vitro and in vivo |
| Q93129624 | Hypoxic exosomes facilitate angiogenesis and metastasis in esophageal squamous cell carcinoma through altering the phenotype and transcriptome of endothelial cells |
| Q44759466 | Identification of CD300a as a new hypoxia-inducible gene and a regulator of CCL20 and VEGF production by human monocytes and macrophages |
| Q64101974 | Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer |
| Q39377200 | Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine |
| Q52561274 | Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - An illustration with firsthand examples. |
| Q37784096 | Inflammation and cancer: macrophage migration inhibitory factor (MIF)--the potential missing link |
| Q26770029 | Innate immunity and hepatocarcinoma: Can toll-like receptors open the door to oncogenesis? |
| Q38501776 | Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation |
| Q38311815 | Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. |
| Q53173976 | Intracellular Wnt/Beta-Catenin Signaling Underlying 17beta-Estradiol-Induced Matrix Metalloproteinase 9 Expression in Human Endometriosis. |
| Q35100014 | Intracellular coexpression of CXC- and CC- chemokine receptors and their ligands in human melanoma cell lines and dynamic variations after xenotransplantation. |
| Q60961187 | Isoliquiritin Apioside Suppresses Invasiveness and Angiogenesis of Cancer Cells and Endothelial Cells |
| Q38429293 | LAMP3 promotes the invasion of osteosarcoma cells via SPP1 signaling |
| Q64274739 | Limitations of Anti-Angiogenic Treatment of Tumors |
| Q85880902 | Lipoxin A4 suppresses lipopolysaccharide-induced hela cell proliferation and migration via NF-κB pathway |
| Q41471434 | Lymph node metastasis and the physicochemical micro-environment of pancreatic ductal adenocarcinoma xenografts |
| Q37987842 | Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity |
| Q39376527 | Membrane-bound and exosomal metastasis-associated C4.4A promotes migration by associating with the α(6)β(4) integrin and MT1-MMP. |
| Q38393014 | Meta-analysis and gene set analysis of archived microarrays suggest implication of the spliceosome in metastatic and hypoxic phenotypes |
| Q35935026 | Metabolic abnormalities in pituitary adenoma patients: a novel therapeutic target and prognostic factor |
| Q28394526 | Metastasis suppressor genes at the interface between the environment and tumor cell growth |
| Q35370402 | Metastasis-associated gene, mag-1 improves tumour microenvironmental adaptation and potentiates tumour metastasis. |
| Q102141796 | Metastasis: crosstalk between tissue mechanics and tumour cell plasticity |
| Q38095501 | MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer |
| Q39415390 | Micrometer-scale oxygen delivery rearranges cells and prevents necrosis in tumor tissue in vitro. |
| Q36917436 | Modeling the mechanics of cancer: effect of changes in cellular and extra-cellular mechanical properties |
| Q35064453 | Molecular and functional imaging of invasion and metastasis: windows into the metastatic cascade |
| Q34914057 | Movers and shakers: cell cytoskeleton in cancer metastasis |
| Q87126886 | Netrin-1 induces epithelial-mesenchymal transition and promotes hepatocellular carcinoma invasiveness |
| Q90455622 | New Directions in the Study and Treatment of Metastatic Cancer |
| Q93055148 | Next-Generation Sequencing Panel Analysis of Clinically Relevant Mutations in Circulating Cell-Free DNA from Patients with Gestational Trophoblastic Neoplasia: A Pilot Study |
| Q89540121 | Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial |
| Q48210066 | Novel Molecular Mechanism of Regulation of CD40 Ligand by the Transcription Factor GLI2. |
| Q91942285 | Organizing pneumonia secondary to lung cancer of unknown primary site |
| Q39135331 | Oxygen distribution in tumors: a qualitative analysis and modeling study providing a novel Monte Carlo approach. |
| Q39017204 | PPARδ deficiency disrupts hypoxia-mediated tumorigenic potential of colon cancer cells |
| Q91773961 | PTBP3 contributes to colorectal cancer growth and metastasis via translational activation of HIF-1α |
| Q33439635 | Phase I study of pazopanib plus TH-302 in advanced solid tumors |
| Q36297745 | Production of Uniform 3D Microtumors in Hydrogel Microwell Arrays for Measurement of Viability, Morphology, and Signaling Pathway Activation |
| Q37971591 | Proline metabolism and cancer |
| Q28301777 | Q6, a novel hypoxia-targeted drug, regulates hypoxia-inducible factor signaling via an autophagy-dependent mechanism in hepatocellular carcinoma |
| Q35185336 | ROS enhances CXCR4-mediated functions through inactivation of PTEN in prostate cancer cells |
| Q28068654 | Relationship between hypoxia and response to antiangiogenic therapy in metastatic colorectal cancer |
| Q90277895 | Rhaponticin decreases the metastatic and angiogenic abilities of cancer cells via suppression of the HIF‑1α pathway |
| Q58702065 | Role of COX-2/PGE2 Mediated Inflammation in Oral Squamous Cell Carcinoma |
| Q92372937 | Role of the RAB7 Protein in Tumor Progression and Cisplatin Chemoresistance |
| Q39395549 | Roles of HIF-1α in a novel optical orthotopic spontaneous metastatic bladder cancer animal model |
| Q37404757 | STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells |
| Q31132835 | STAT3 or USF2 contributes to HIF target gene specificity |
| Q38743015 | Secretome derived from breast tumor cell lines alters the morphology of human umbilical vein endothelial cells. |
| Q33763551 | Significance of talin in cancer progression and metastasis |
| Q89367617 | Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment |
| Q57044552 | Sorafenib inhibits caspase-1 expression through suppressing TLR4/stat3/SUMO1 pathway in hepatocellular carcinoma |
| Q38172858 | Stimuli-induced organ-specific injury enhancement of organotropic metastasis in a spatiotemporal regulation. |
| Q92977325 | Stoichioproteomics reveal oxygen usage bias, key proteins and pathways in glioma |
| Q36581353 | Symptomatic cardiac metastases of breast cancer 27 years after mastectomy: a case report with literature review--pathophysiology of molecular mechanisms and metastatic pathways, clinical aspects, diagnostic procedures and treatment modalities |
| Q37093119 | TLR4 is a novel determinant of the response to paclitaxel in breast cancer |
| Q57291853 | Targeted Theranostic Nanoparticles for Brain Tumor Treatment |
| Q91895956 | The Crucial Role of CXCL8 and Its Receptors in Colorectal Liver Metastasis |
| Q38985464 | The Solid Mechanics of Cancer and Strategies for Improved Therapy |
| Q38210012 | The double-edged sword: conserved functions of extracellular hsp90 in wound healing and cancer |
| Q28079015 | The ever-expanding role of HIF in tumour and stromal biology |
| Q36972016 | The metastasis-promoting roles of tumor-associated immune cells |
| Q35864968 | The molecular biology of brain metastasis |
| Q101476066 | The novel interplay between CD44 standard isoform and the caspase-1/IL1B pathway to induce hepatocellular carcinoma progression |
| Q35440270 | The primary cilium as a biomarker in the hypoxic adaptation of bone marrow-derived mesenchymal stromal cells: a role for the secreted frizzled-related proteins |
| Q37964960 | The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma |
| Q37836613 | The role of nuclear pore complex in tumor microenvironment and metastasis |
| Q39439223 | The unfolded protein response controls induction and activation of ADAM17/TACE by severe hypoxia and ER stress |
| Q36570909 | The β2-adrenoceptor activates a positive cAMP-calcium feedforward loop to drive breast cancer cell invasion. |
| Q37851151 | Therapeutic targeting of tumor-stroma interactions. |
| Q30924798 | Toward predicting metastatic progression of melanoma based on gene expression data |
| Q48567245 | Tumor chemosensitization by physical exercise? Insights from an anidmal model. |
| Q34347257 | Tumor interstitial fluid pressure-a link between tumor hypoxia, microvascular density, and lymph node metastasis |
| Q47105842 | Tumor necrosis and complete resection has significant impacts on survival in patients with limited-stage upper aerodigestive tract NK/T cell lymphoma |
| Q90319010 | Tumor progression-dependent angiogenesis in gastric cancer and its potential application |
| Q26747678 | Tumor refractoriness to anti-VEGF therapy |
| Q37127042 | Tumor-infiltrating monocytes/macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cells. |
| Q36362933 | Upstream stimulatory factor 2 and hypoxia-inducible factor 2α (HIF2α) cooperatively activate HIF2 target genes during hypoxia |
| Q39285839 | Vinorelbine inhibits angiogenesis and 95D migration via reducing hypoxic fibroblast stromal cell-derived factor 1 secretion |
| Q38219611 | Wound infections and healing: are they contributing factors for carcinogenesis? |
| Q39007411 | c-Myc-mediated repression of miR-15-16 in hypoxia is induced by increased HIF-2α and promotes tumor angiogenesis and metastasis by upregulating FGF2. |
| Q36838575 | αB-crystallin, an effector of unfolded protein response, confers anti-VEGF resistance to breast cancer via maintenance of intracrine VEGF in endothelial cells |
Search more.